JG-1

JG-1 most specifically refers to an experimental small-molecule antibiofilm compound reported in academic infectious-disease literature. It inhibits formation of and disperses established bacterial biofilms, particularly in *Salmonella* models and across several ESKAPE-associated pathogens, without a clearly defined single molecular target. Available mechanistic work suggests its activity is linked to disruption of protein interactions important for biofilm maintenance and virulence, with effects influenced by proteins such as OmpA, OmpC, and TrxA, but the precise direct target remains unresolved. JG-1 appears to be a research-stage compound rather than a clinically developed or approved pharmaceutical product.